Table 2.
Hamster models important for evaluation of protective immunity versus endpoint of severe destructive Lyme arthritis.
| Model | B. burgdorferi strains | Timing of immunogen delivery | Endpoint | Comments | Reference(s) |
|---|---|---|---|---|---|
| Irradiated hamster (challenge) | Numerousa | Following 550 rads gamma radiation | SDLAb | Adoptive transfer (protection) experiments | [18, 21, 22] |
| Irradiated hamster (vaccination/challenge) | Numerousa | Challenge prior to development of significant borreliacidal antibody titer (homologous challenge)c; timing of heterologous strain challenge can vary | SDLA | Assessment of vaccine candidates | [24] |
| Immunocompetent hamster (vaccination/challenge) | Numerousd | Challenge prior to development of significant borreliacidal antibody titer (homologous challenge)c; timing of heterologous strain challenge can vary | SDLA | Characterizing duration of protective immunity of vaccine candidates; Assessing Lyme borreliosis vaccine candidates for adverse events |
[20, 25] [29, 35] |
aReferenced study(ies) focused on B. burgdorferi sensu stricto isolate 297.
bSevere destructive Lyme arthritis.
dReferenced study(ies) focused on B. bissettii vaccination with subsequent B. burgdorferi sensu stricto isolate 297 challenge.